DOB-FLY, also known as 3C-B-FLY or as B-FLY, is a psychedelic drug and designer drug of the phenethylamine, amphetamine, DOx, and FLY families. It is the FLY derivative of DOB, the amphetamine (ñ-methyl) derivative of 2C-B-FLY, and the partially saturated analogue of Bromo-DragonFLY (DOB-DFLY).
Unlike Bromo-DragonFLY, DOB-FLY is only slightly more potent than DOB itself, with an active dose in humans of around 1mg orally (compared to 1âÂÂ3mg orally for DOB).
Analogues of DOB-FLY include DOB, 2C-B-FLY, Bromo-DragonFLY (DOB-DFLY), TFMFly (TFM-FLY), and DOB-5-hemiFLY, among others.
DOB-FLY was developed by David E. Nichols and colleagues at Purdue University. It is a controlled substance in Canada under phenethylamine blanket-ban language, but is not explicitly controlled in the United States.